Dr. Marie Ann Eason, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Lane, Largo, MD 20774 Phone: 301-618-5500 Fax: 301-618-5673 |
Dr. Thorsten Sundberg, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 |
Dr. Robert A Ferris, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 |
Vinh C Nguyen, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 |
Dr. Delia Depaola, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 |
Dr. Shashi H Ranganath, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 |
Dr. Jesse D Dawkins Sr., M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 |
News Archive
TechniScan, Inc.'s cofounder and scientist-mathematician, James Wiskin, Ph.D, will be a presenting speaker at the SPIE Medical Imaging Conference in San Diego this weekend.
Long-term survivors after esophagectomy with gastric pull-up can enjoy a satisfying meal and good quality of life according to a new study from a team of researchers at the University of Southern California Keck School of Medicine, Los Angeles.
Molecular Health has entered into a commercial license to provide the FDA with use of its SafetyMAP software - formally known as Molecular Analysis of Side Effect information (MASE), to provide a comprehensive and dynamic analytical solution for the detection and molecular analysis of drug-induced adverse events for all marketed drugs and for predicting safety issues of new drug candidates.
Mayo Clinic has reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy.
› Verified 8 days ago